(Q33574578)

28 July 2017

title

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). (English)

1 reference

28 July 2017

1 reference

1 reference

Lisa M Deangelis

11

0 references

Minesh Mehta

object named as

Minesh Mehta

12

0 references

Patrick Y Wen

1

object named as

Patrick Y Wen

1 reference

28 July 2017

5

Timothy F Cloughesy

1 reference

28 July 2017

18

Rakesh K Jain

1 reference

28 July 2017

6

Lauren E Abrey

1 reference

28 July 2017

14

Jan Drappatz

1 reference

28 July 2017

W K Alfred Yung

2

1 reference

28 July 2017

Kathleen R Lamborn

3

1 reference

28 July 2017

Andrew D Norden

4

1 reference

28 July 2017

Howard A Fine

7

1 reference

28 July 2017

Susan M Chang

8

1 reference

28 July 2017

H Ian Robins

9

1 reference

28 July 2017

Karen Fink

10

1 reference

28 July 2017

Emmanuelle Di Tomaso

13

1 reference

28 July 2017

Santosh Kesari

15

1 reference

28 July 2017

Keith L Ligon

16

1 reference

28 July 2017

Ken Aldape

17

1 reference

28 July 2017

Charles D Stiles

19

1 reference

28 July 2017

Merrill J Egorin

20

1 reference

28 July 2017

Michael D Prados

21

1 reference

28 July 2017

publication date

1 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

853-860

1 reference

Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Targeted drug therapy for meningiomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Salvage chemotherapy with CPT-11 for recurrent meningioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Clinical pharmacokinetics of imatinib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Temozolomide for treatment-resistant recurrent meningioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Platelet-derived growth factor in human brain tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Epidemiology and etiology of intracranial meningiomas: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Meningioma: analysis of recurrence and progression following neurosurgical resection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

The Meningioma Controversy: Postoperative radiation therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

The role of radiotherapy in the treatment of subtotally resected benign meningiomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study

21 June 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Expression and activation of epidermal growth factor receptors in meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-010

Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802405

Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas

31 October 2018

1 reference

12 December 2020

Expression of PDGF β-receptors in human meningioma cells

1 reference

12 December 2020

Platelet-derived growth factor expression and stimulation in human meningiomas

1 reference

12 December 2020

Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor

1 reference

12 December 2020

Radiotherapy for meningiomas

1 reference

12 December 2020

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B

1 reference

12 December 2020

Hydroxyurea for treatment of meningioma

1 reference

12 December 2020

Long-term outcomes after meningioma radiosurgery: physician and patient perspectives

1 reference

12 December 2020

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

12 December 2020

10.1215/15228517-2009-010

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference